COMPASS FINANCIAL MANAGEMENT LLC’s iShares Biotechnology ETF IBB Stock Holding History

COMPASS FINANCIAL MANAGEMENT LLC’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$56.3K	Buy	+296	New	+$50.9K	0.01%	668

Other funds holding IBB

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

COMPASS FINANCIAL MANAGEMENT LLC's IBB Position: Q2 2026 in Review

COMPASS FINANCIAL MANAGEMENT LLC opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 296 shares worth $56.3K. The stake represents 0.01% of the portfolio and ranks #668 among its holdings.

800 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

COMPASS FINANCIAL MANAGEMENT LLC held 296 shares of iShares Biotechnology ETF worth $56.3K as of Q2 2026.
iShares Biotechnology ETF was a new COMPASS FINANCIAL MANAGEMENT LLC position in Q2 2026.
iShares Biotechnology ETF made up 0.01% of COMPASS FINANCIAL MANAGEMENT LLC's portfolio in Q2 2026, its #668 holding.
800 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on COMPASS FINANCIAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 12 Aug 2026.